Member Info for MrRipley

I must have been Sensing Avevas RNS.

Tomorrow it is then.

No need to thank me.

199 shares! Must be wres, he’s found 250 quid in paper fivers in an old pair of chords and put the lot on us, adding it to his 50k shares to bring his total up to 260k.

No need to thank me.

Well done everyone.

1.50-1.505 opening.

Sorry just never seen a slower and more boring day here.

Not even a dip to get the heart racing.

12. Not 18. One followed for 25 months. The rest followed for 6.

“On August 17, 2021, the U.S. Food and Drug Administration (FDA) granted accelerated approval to dostarlimab for adults with mismatch repair deficient (dMMR) recurrent or advanced solid tumors, as determined by an FDA-approved test, that have progressed on or following prior treatment and who have no satisfactory alternative treatment options”

Why “no satisfactory alternative treatment options”? Cost? It’s been approved for use since April 2021

The 150 opening didnt feel like I expected 150 to feel. I thought it would feel about 27p better.

No French fisting!? I’m very relieved to here this. With my hay fever playing up that would be more eye watering than I can handle.

Live Data, when did we get a listing in France? Do you think you’re on the NCYT page?

French listing????? Am I on spice today? Feel like there’s some bizarre posting going on. Do we all know the markets also closed today?

It’s simple really. Getting AVA6000 through trials is the most important moment this company will ever have. Spending time and money on the LFT when quite frankly nobody has any intention of buying and LFT and the likes of UKGov have their source of tests locked in, would be a monumental mistake. People are over covid whether it’s still here or not. Forget the LFT. It’s done.
Maybe if AVA gets through trials and we bring in some serious revenue should the idea of LFTs for other disease be more seriously pursued. But for now Avacta do not have the funds to do so. The focus must be precision.

Is there any evidence out there what the Dox market is worth if AVA6000 works, and it allows for a greater range of patients who would otherwise not qualify for its use? Also, what would the platform as a whole be worth? Would it have a knock on into the potential of TMAC working? What happens when you add in partnerships?

The possibilities here are ridiculous. But first….. it has to work. And all here have to be patient.

100% you’re NDN.

Id Rarely say this but Well Done everyone.

Tar tar.

Real meat-ing if comedy minds here. Maybe we should stop porking fun at this thread now.

Sausage.

Love a steak. More of a fried chicken or lamb chop man myself though.

I’ll continue to pull the likes of Mr A. Filter me if you don’t like it. I honestly don’t care. But when this prat posts that the report remarks on the LFT, which is absolutely not the focus of the company is a disaster in attempt to cause unrest, I’ll pull it. Filter me.

Here’s you on the ODX board.

“This share is now oversold, Bighero will retake a position. However, if your average is over 50 you will only make your money back. If your average is over 60, you are stuffed like a bird at Christmas. If your average is 25/26 like me, you will make some excellent money.”

ODX is 3.75p. 3% of it’s high. Three. Percent.

I’ve got a fantastic memory for twats. And you’re one of them busybuilder. You aren’t invested. You’re just a scumbag.

“BusyBuilder
Posted in: AVCT
Posts: 254
Price: 62.50
No Opinion
RE: Is it time10 Feb 2022 13:57
Apparently, not just yet. Soon though.

So glad I sold out earlier, even at a 55% loss.”

Enjoy your loss. **** for brains.

Welcome back Chengdo. God it’s just like 2020 again. With some subtle name changes. All we need now is Jim Spark to make a return.

Richar.

On WhatsApp